Old Port Advisors Sells 3,718 Shares of Haleon plc (NYSE:HLN)

Old Port Advisors decreased its stake in shares of Haleon plc (NYSE:HLN) by 17.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 17,907 shares of the company’s stock after selling 3,718 shares during the quarter. Old Port Advisors’ holdings in Haleon were worth $171,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Bank of New York Mellon Corp increased its stake in Haleon by 13.7% during the second quarter. Bank of New York Mellon Corp now owns 1,572,542 shares of the company’s stock valued at $12,989,000 after acquiring an additional 189,519 shares during the period. Allspring Global Investments Holdings LLC increased its position in shares of Haleon by 249.4% during the second quarter. Allspring Global Investments Holdings LLC now owns 17,704 shares of the company’s stock valued at $146,000 after purchasing an additional 12,637 shares during the period. Rothschild Investment LLC acquired a new position in shares of Haleon in the second quarter valued at $60,000. Concurrent Investment Advisors LLC raised its stake in shares of Haleon by 10.7% in the second quarter. Concurrent Investment Advisors LLC now owns 16,906 shares of the company’s stock valued at $140,000 after purchasing an additional 1,635 shares in the last quarter. Finally, Natixis Advisors LLC lifted its position in Haleon by 10.8% in the second quarter. Natixis Advisors LLC now owns 607,697 shares of the company’s stock worth $5,020,000 after purchasing an additional 59,099 shares during the period. Institutional investors and hedge funds own 6.67% of the company’s stock.

Analyst Upgrades and Downgrades

HLN has been the subject of a number of recent research reports. UBS Group upgraded shares of Haleon to a “strong-buy” rating in a research note on Tuesday, October 1st. Morgan Stanley increased their price target on shares of Haleon from $9.90 to $10.95 and gave the stock an “overweight” rating in a research report on Friday, September 20th. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $10.95.

Haleon Stock Down 1.0 %

Shares of NYSE HLN opened at $9.44 on Friday. The business has a fifty day moving average of $9.64 and a two-hundred day moving average of $9.63. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. Haleon plc has a 52-week low of $7.89 and a 52-week high of $10.80. The stock has a market cap of $42.73 billion, a PE ratio of 27.76, a PEG ratio of 2.95 and a beta of 0.28.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.